Urgent.News

What's breaking now, across thousands of outlets.

Culture

Where Will Eli Lilly Be in 10 Years? 1 Clue: Its Next Potential Blockbuster Just Beat Ozempic Head-to-Head

Key PointsRetatrutide beat Ozempic in a head-to-head trial, highlighting Lilly’s dominance in its core area.

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Every outlet that reported this, and when →

Read the original at nasdaq.com →

More in Culture

More from Monday 16 November →